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AVALIAÇÃO DO ACESSO AO TRATAMENTO DE TUBERCULOSE POR COINFECTADOS 
OU NÃO PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA
EVALUACIÓN DEL ACCESO AL TRATAMIENTO DE TUBERCULOSIS POR 
COINFECTADOS O NO POR EL VIRUS DE INMUNODEFICIENCIA HUMANA
Ana Maria da Silveira Rodrigues1, Lúcia Marina Scatena2, Silvia Helena Figueiredo Vendramini3, 
Silvia Rita Marin da Silva Canini4, Tereza Cristina Scatena Villa5, Elucir Gir6
RESUMO
Este estudo objeƟ vou avaliar o acesso ao tra-
tamento das pessoas com tuberculose tanto 
coinfectadas ou não pelo Vírus da Imunode-
fi ciência Humana (HIV). Trata-se de estudo 
transversal – com uƟ lização do instrumento 
Primary Care Assessment Tool aplicado a 95 
pessoas – que abordou questões sobre o 
acesso ao tratamento em município do in-
terior paulista. Para avaliação do acesso ao 
tratamento, uƟ lizou-se o teste t de Student. 
Os escores médios das variáveis foram ana-
lisados individualmente e comparados entre 
os dois grupos (pessoas com TB e coinfecta-
das com HIV e pessoas com TB não coinfecta-
das pelo HIV). Os escores médios mostraram 
que as coinfectadas pelo HIV apresentaram 
maiores difi culdades na obtenção do acesso 
do que as não coinfectadas. Os profi ssionais 
visitavam mais vezes as coinfectadas quando 
comparadas às não coinfectadas; as coinfec-
tadas quase nunca realizavam o tratamento 
da doença em posto de saúde perto de sua 
residência. Há, portanto, necessidade de 
maior integração e comunicação entre os 
Programas de Tuberculose e DST/aids.
DESCRITORES 
Tuberculose
HIV
Acesso aos Serviços de Saúde
Direitos do paciente
Enfermagem em saúde pública
ABSTRACT
This study aimed to evaluate accessibil-
ity to treatment for people with TB co-in-
fected or not with HIV. This cross-secƟ onal 
study addressed issues regarding accessi-
bility to treatment in a city in the interior 
of São Paulo state, Brazil. The instrument 
Primary Care Assessment Tool was uƟ lized 
with 95 people. To evaluate access to treat-
ment, Student’s t test was used. The mean 
scores of variables were analyzed sepa-
rately and compared between two groups 
(people with TB co-infected with HIV and 
people with TB not co-infected with HIV ). 
Mean scores showed that HIV co-infected 
people presented greater diﬃ  culƟ es in 
gaining access than those not co-infected. 
Professionals visited co-infected people 
more oŌ en when compared to those not 
co-infected; the co-infected people almost 
never accessed treatment for their disease 
in the Health Unit nearest their home. 
There is, therefore, the need for greater 
integraƟ on and communicaƟ on between 
the programs for treatment of Tuberculosis 
and STD/AIDS.
DESCRIPTORS 
Tuberculosis
HIV
Health Services Accessibility
PaƟ ent rights
Public health nursing
RESUMEN 
Se objeƟ vó evaluar el acceso al tratamien-
to de personas con tuberculosis, coinfec-
tadas o no por Virus de Inmunodefi cien-
cia Humana (VIH). Estudio transversal, 
uƟ lizando el instrumento Primary Care 
Assessment Tool, aplicado a 95 personas; 
abordó cuesƟ ones sobre acceso al trata-
miento en municipio del interior paulista. 
Para dicha evaluación, se uƟ lizó el test T 
de Student. Los puntajes medios de las 
variables se analizaron individualmente y 
fueron comparados entre los dos grupos 
(pacientes con TB coinfectadas y no coin-
fectadas con HIV). Los puntajes promedio 
expresaron que los coinfectados con HIV 
presentaron mayores difi cultades de ac-
ceso que las no coinfectadas. Los profe-
sionales visitaban más a los coinfectados 
en comparación con los no coinfectados; 
los coinfectados casi nunca realizaban tra-
tamiento de su enfermedad en puestos 
sanitarios cercanos a su domicilio. Existe, 
consecuentemente, necesidad de mayor 
integración y comunicación entre los Pro-
gramas de Tuberculosis y DST/SIDA.
DESCRIPTORES 
Tuberculosis
VIH
Accesibilidad a los Servicios de Salud
Derechos del paciente
Enfermería en salud publica
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INTRODUCTION
Tuberculosis (TB) is considered a neglected disease, al-
though it represents an important cause of morbidity and 
mortality worldwide, especially aŌ er the appearance of HIV 
in 1981. This event changed the epidemiology of TB, result-
ing in greater diﬃ  culty in controlling it.(1). In addiƟ on to 
AIDS, other cumulaƟ ve factors have enhanced the diﬃ  culty 
in treaƟ ng TB, such as poverty, lack of educaƟ on, non-exist-
ing or improper housing condiƟ ons, malnutriƟ on, alcohol-
ism, under fi nancing of public health programs, mulƟ -drug 
resistance to the organism causing TB, as well as the aging 
and large migraƟ ons of certain populaƟ on(2).
The associaƟ on of the TB virus and the HIV virus (hu-
man immunodefi ciency virus) is of great concern to sani-
tary and governmental authoriƟ es, considering that the 
evoluƟ on from TB carrier status to the infecƟ on causing ill-
ness in immunocompromised paƟ ents is 10% throughout 
their lives. However, among HIV-infected paƟ ents, the risk 
of this evoluƟ on occurring reaches 8 to 10 % per year(1).
In 2008, in the city of São José do Rio 
Preto, the coeﬃ  cient of TB occurrences 
reached 28.1/100,000 inhabitants, lower 
than the rate for the State of São Paulo 
(37.5/100,000 inhabitants) and the rate 
for the country (37.5/100,000 inhabit-
ants). When HIV is regarded, the situa-
Ɵ on is inverted: 24.7/100,000 inhabitants, 
19.5/100,000 inhabitants and 18.1/100,000 
inhabitants, respecƟ vely (3-5). These staƟ s-
Ɵ cs demonstrate the importance of these 
disease epidemics to the city, considering 
that the combinaƟ on of these two diseases 
represents an issue of concern to the local 
health authoriƟ es, since HIV increases TB 
epidemics and is the main cause of death of HIV carriers.
HIV tesƟ ng for paƟ ents carrying TB is important due 
to the high prevalence of Mycobacterium tuberculosis and 
HIV co-infecƟ on, and also since its presence cannot be 
determined in co-infected paƟ ents based solely on their 
clinical history(6).
Primary Healthcare has been responsible for the ac-
Ɵ ons of the NaƟ onal TB Control Program (NTBCP) since 
2001, and these acƟ ons can be executed through services 
within the Family Health Program and in tradiƟ onal clinic 
services with a verƟ cal organizaƟ on model and a special-
ized team. In 2006, TB was included as a strategic acƟ on 
in the NaƟ onal Plan of Primary Healthcare with monitored 
and evaluated indexes(7).
Throughout the country, the NaƟ onal TB Control Pro-
gram is not totally integrated with the HIV Control Pro-
gram, which concentrates its care network within the 
secondary and terƟ ary care levels. For this reason, since 
2004, aƩ empts to incorporate co-infecƟ on with TB/HIV 
within the TB control policies were developed, with a view 
to invesƟ ng eﬀ orts in social mobilizaƟ on and obtaining 
the same successful results achieved in HIV control pro-
grams(8). However, there are sƟ ll diﬃ  culƟ es in achieving 
the TB control targets in face of the negaƟ ve impact of 
one disease over the other, mainly due to the high death 
rates among HIV carriers undergoing TB treatment(9).
The organizaƟ on of health services under the auspices 
of Primary Healthcare are requires the accomplishment 
of the access dimension. Access is a mulƟ dimensional 
concept that expresses a compound of features enhanc-
ing or limiƟ ng the ability of people to use health services 
when they need them(10). It depends, at the same Ɵ me, 
on the combinaƟ on of available human and physical re-
sources and on the fi nancial and administraƟ ve systems 
that determine which individuals will receive these servic-
es and under which condiƟ ons. Thus, access is associated 
with factors such as: the type of care required in terms of 
the clients’ needs, access and admiƩ ance criteria, labor 
allocaƟ on, funcƟ oning hours, and service quality(11). Ac-
cess is an important Primary Healthcare impact indicator. 
It allows for the ability to evaluate the ex-
tent to which this component has reached 
the clientele, consƟ tuƟ ng an important tool 
for improvement in the Unifi ed Health Sys-
tem(12). Therefore, in the described scenario, 
evaluaƟ ng the access to treatment for cli-
ents with HIV and/or TB is viewed as a need, 
so that TB carriers who also have HIV are ef-
fi ciently treated.
By exploring this situaƟ on, the objecƟ ve 
of this present study was to evaluate the ac-
cess to treatment of TB carriers co-infected 
(or not) with HIV.
METHOD
This is a cross-secƟ onal study performed in the Health 
Units of the NaƟ onal TB Control Program (NTBCP) in the 
city of São José do Rio Preto, between June of 2006 and 
July of 2007. The individuals selected were undergoing 
treatment during this period and fulfi lled the inclusion cri-
teria: 18 years old or over; confi rmed TB diagnosis; and 
living in the city at the Ɵ me of diagnosis. AŌ erwards, in-
dividuals who tested posiƟ ve for HIV were selected, along 
with those who tested negaƟ ve.
For data collecƟ on, the Primary Care Assessment Tool 
(PCAT)(10) quesƟ onnaire was used. This quesƟ onnaire was 
validated and deemed suitable for use in Brazil by Macinko 
and Almeida in 2006,(13) and aŌ erwards adjusted for TB 
clients by Villa and Ruﬃ  no-NeƩ o in 2008(14). Interviewees 
answered the quesƟ onnaire, which included quesƟ ons re-
garding each Primary Healthcare dimension: accessibility, 
entrance, aƩ achment, range of services, coordinaƟ on (or 
services integraƟ on), professional training, and general 
...the National TB 
Control Program is 
not totally integrated 
with the HIV Control 
Program, which 
concentrates its care 
network within the 
secondary and tertiary 
care levels.
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and socio-demographic informaƟ on about the TB carrier. 
In this present study, only the results pertaining to access 
to treatment were considered.
Interviewees answered each quesƟ onnaire item ac-
cording to a pre-established Likert scale, with possible 
answers ranging from zero to fi ve. The zero value was at-
tributed to the I don’t know or does not apply answers, 
and the values from one to fi ve registered an escalaƟ ng 
preference (or agreement) to the statements. For each 
quesƟ on, a mean score was determined corresponding 
to the sum of all scores (categories) from individuals an-
swers, divided by the total number of interviewees. The 
mean scores were classifi ed as: non-saƟ sfactory (values 
near and between one and two); moderately saƟ sfactory 
(near three) and saƟ sfactory (near four and fi ve). Regard-
ing general and socio-demographic informaƟ on about the 
TB carrier, the interviewees answered each quesƟ on of 
the quesƟ onnaire according to a varied scale of answers.
In order to proceed with data collecƟ on, all paƟ ents 
co-infected with TB and HIV were invesƟ gated by means 
of TBWEB throughout the period of the study. Interview-
ees received training regarding the use of the instrument. 
Explanatory scripts were used regarding the instrument 
answer scales, directed to the individuals.
The general and socio-demographic informaƟ on was 
analyzed using frequency tables. The Chi-Square test 
was employed in calculaƟ ng the proporƟ ons between 
the variables gender and living locaƟ on for the group of 
individual carriers of TB who were co-infected with HIV, 
and for the other group of individual carriers of TB not 
infected with HIV.
In order to evaluate access to treatment, data were sub-
miƩ ed to the Student t test. The mean score of the vari-
ables were individually analyzed and compared between 
the two groups (individual carriers of TB co-infected with 
HIV and individual carriers of TB not infected with HIV).
All analyses were performed using the StaƟ sƟ cs pro-
gram 8.0 (StatsoŌ ).
The study proposal was evaluated and approved (pro-
tocol number 0762/2007) by the Research Ethics Commit-
tee of the University of São Paulo at Ribeirão Preto Col-
lege of Nursing, in accordance with ResoluƟ on 196/96 of 
the NaƟ onal Health Council. All parƟ cipants voluntarily 
signed a Free and Informed Consent Form.
RESULTS
Of the 106 individuals with TB undergoing treatment 
throughout the described period, 11 (10.5%) were not 
tested for HIV.
All individuals not tested for HIV were excluded from 
the analysis. Thus, this present study included 95 parƟ ci-
pants. Among these parƟ cipants 73(68.8%) had TB and 
were not co-infected with HIV; 22 (23.2%) had TB and 
were co-infected with HIV.
Regarding gender, 63 (66.3%) were males (64.4% were 
carriers of TB and 72.7% of the TB paƟ ents were co-infect-
ed by HIV) and 66 (69.5%) had a complete primary educa-
Ɵ on. When the variables gender and co-infecƟ on with HIV 
or no co-infecƟ on present were analyzed, we observed 
that there was not a staƟ sƟ cal associaƟ on between them 
(p=0.468).
Regarding the housing situaƟ on of these individuals, 
48 (50.5%) were living in their own houses; 26 (27.4%) in 
rentals; 15 (15.8%) in fi nanced homes and 6 (6.3%) de-
clared being homeless.
Type of housing was divided into the four following 
categories: brick built, wood, recycled material and oth-
ers. Most individuals lived in housing built from bricks, no 
cases of recycled material housing or other types of hous-
ing were disclosed, and only one individual (1.1%) lived in 
a house made of wood.
There was no associaƟ on between the individuals’ co-in-
fecƟ on status and the type of housing they lived in (p=0.970), 
since the fact that individual carriers of TB were living in his/
her own homes, rentals, fi nanced homes, or were homeless 
had no infl uence on being a TB carrier co-infected with HIV.
Table 1 presents mean scores, the standard deviaƟ on 
and the staƟ sƟ cal signifi cance p- value for the type I error 
probability of the variables that represent the access to 
treatment for individual carriers of TB who tested nega-
Ɵ ve for HIV and those carriers of TB co-infected with HIV.
Individuals co-infected with TB and HIV presented 
lower mean scores compared to individual carriers of TB 
who tested negaƟ ve for HIV for the following variables: 
obtaining informaƟ on by phone from the health service 
center; diﬃ  culty in booking appointments by phone; the 
need to miss a whole day of work due to the appoint-
ment; the need to use special transportaƟ on to get to the 
appointment; expenditure needs for transportaƟ on for 
the appointment; lack of medicaƟ on for treatment; wait-
ing Ɵ me of more than an hour prior to appointments; and 
receiving treatment in a health center near the housing 
locaƟ on. These scores were classifi ed non-saƟ sfactory to 
moderately saƟ sfactory. Moreover, the score regarding 
receiving treatment in a health center near the housing 
locaƟ on variable was staƟ sƟ cally signifi cant.
Regarding carriers of TB not infected with HIV, the 
mean scores were lower than the scores for individual car-
riers of both TB and HIV for the following variables: book-
ing an appointment within 24 hours in case of medicaƟ on 
side eﬀ ects and house calls by professionals for treatment 
follow-up. These scores were classifi ed between non-sat-
isfactory and moderately saƟ sfactory. The score for house 
calls by a professional for treatment follow-up was also 
staƟ sƟ cally signifi cant.
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DISCUSSION
Regarding sociodemographic characterisƟ cs of car-
riers of TB co-infected with HIV, there is a prevalence of 
male individuals: 64.4% are carriers of TB and 72.7% are 
co-infected with HIV.
These data corroborate the results from other stud-
ies that analyzed the gender variable associated with TB 
and HIV, and also the predominance of the male gender, 
confi rming men’s higher vulnerability to and prevalence 
of Mycobacterium tuberculosis and HIV co-infecƟ on(6,15).
Regarding educaƟ on, results demonstrate primary ed-
ucaƟ on as being the main level achieved, both for carriers 
of TB and for HIV co-infecƟ on. Other studies demonstrate 
the same reality, showing that low educaƟ onal levels may 
be refl ected in their job posiƟ ons, constraining these in-
dividuals to unfavorable life and employment condiƟ ons, 
maintaining their poverty status and therefore making 
health self- promoƟ on diﬃ  cult(6,16).
Regarding housing condiƟ ons, most individuals 
dwelled in brick housing. These data are congruent with 
other studies(16).
Regarding access to treatment, in analyzing the vari-
ables contained in this present study, the majority of 
scores are higher for individuals only infected with TB, ex-
cepƟ ng two variables. Co-infected individuals presented 
higher scores regarding booking an appointment within 
less than 24 hours for cases of medicaƟ on side eﬀ ects and 
when there were house calls made by professionals in or-
der to follow up treatment given.
When individuals feel unwell, they tend to request 
health care around the clock, outside normal working 
hours. These services, due to their working hours, should 
provide easier access than other services, providing faster 
health care delivery(17).
The fact that only individual with TB received treat-
ment near their homes may be related to internal orga-
nizaƟ onal aspects of the health units and not due to geo-
graphic locaƟ on. In addiƟ on, this fact may be related to 
the health unit schedule compaƟ bility with the schedule 
availability of some individuals, quality of the service, the 
disease sƟ gma, and the relaƟ onship between health pro-
fessionals and individuals co-infected with HIV(18).
In both cases, saƟ sfactory score levels were presented 
in regards to lack of medicaƟ on and waiƟ ng Ɵ mes of more 
than 60 minutes prior to appointments.
Under this context, the lack of an appropriate orga-
nizaƟ onal policy demonstrates the current status of the 
naƟ onal health system. However, what can be seen does 
not always correlate with the lack of campaigns to dissem-
inate informaƟ on or the importance of performing the 
needed exams for diagnosis, therefore providing faster 
treatment, but also with people’s feelings regarding the 
diagnosis and exams in terms of these diseases.
Diseases such as TB and HIV are historically sƟ gma-
Ɵ zed and the negaƟ ve impact generates drasƟ c conse-
quences in terms of treatment dropouts and elevated 
mortality rates(19).
Studies reveal that these barriers are many Ɵ mes im-
posed by the carriers themselves. Since tesƟ ng for HIV is 
considered discriminatory, individuals can choose not to 
Table 1 – Mean standard deviation of the variables representing the access to treatment for individual carriers of TB co-infected or 
not with HIV
Variables
Tested negative for HIV “n=73” Tested positive for HIV “n=22” Student Test 
Mean and Standard Deviation Mean and Standard Deviation P Value
Booking an appointment within 24 hours in case of 
medication side effects 4.41±1.32 4.50±1.01 0.771
Obtaining information from the health center by 
phone 3.73±1.68 3.36±1.81 0.385
Diffi culty in booking an appointment by telephone 
in the health center. 3.47±1.80 3.23±1.88 0.591
The need to miss a whole day of work due to an 
appointment in the health center 3.23±1.77 2.86±1.93 0.403
Need for special transportation to reach the health 
center 1.67±1.41 1.36±1.18 0.356
Expenditure needs for transportation to the health 
center 2.90±1.86 2.05±1.70 0.056
Medication failure in the treatment of the disease 4.93±0.30 4.91±0.29 0.760
Waiting time of over 60 minutes for the scheduled 
appointment 4.55±0.78 4.27±0.94 0.170
House calls by health professionals for follow-up 
on the treatment 2.75±1.60 3.82±1.30 0.005
*
Treatment appointments in a health center near the 
housing location 3.10±1.73 2.23±1.38 0.033
*
* P - value refers to the t test for independent samples. In bold, p< 0.05, statistics signifi cance level adopted for the test.
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be tested. This fact aggravates TB carrier dynamics, since 
70 of the 165 individual carriers of TB (42.4%) were co-
infected with HIV, contrasƟ ng other studies that demon-
strate, in general, rates around 9% to 18%(15).
Moreover, another important factor that requires at-
tenƟ on is the social condiƟ on of individuals infected with 
these two diseases. All variables studied considering ac-
cess to treatment may be aﬀ ected by these condiƟ ons. 
Most individuals living under unfavorable life and employ-
ment condiƟ ons demonstrate more diﬃ  culty in gaining 
access to treatment(6).
One factor that can be more criƟ cally analyzed is the fact 
that all individuals experienced diﬃ  culƟ es regarding access 
to treatment, regardless of whether they had both diseas-
es or one. In some cases, individuals co-infected with HIV 
presented easier access to appointments within 24 hours 
when experiencing medicaƟ on side eﬀ ects and, in addiƟ on, 
had home visits from health professionals more frequently 
for treatment follow-up. TB carriers do not always receive 
these services appropriately since the nature of HIV is its 
gravity, which is a presumpƟ on for this occurrence.
The strong interacƟ on in these two disease distribu-
Ɵ ons, with the occurrence of one aﬀ ecƟ ng the other, de-
mands cooperaƟ on in control intervenƟ ons developed in 
HIV/TB programs. An arƟ culated interacƟ on of these two 
areas will allow for the improvement of the management 
of resources directed towards personnel training, diagno-
sis of both diseases or infecƟ ons and respecƟ ve treatment 
control. In addiƟ on, it will enable technical argumentaƟ on 
with enough strength to be considered at all poliƟ cal deci-
sion levels. An appropriate response that meets the needs 
of all challenges imposed must show the sustainability of 
the adopted strategies. Thus, planning of acƟ ons must 
be parallel to the incenƟ ve for the development of new 
therapeuƟ c and diagnosƟ c opƟ ons, whether retrovirals, 
anƟ -TB medicaƟ ons or vaccines.
Controlling the treatment of individuals co-infected 
with TB/HIV is even more complex when compared to the 
treatment for individual carriers of TB alone, since these 
individuals have a poor life expectancy. This disease, de-
spite technological progress in understanding the disease 
mechanism, has no cure; hence, treatment dropouts oc-
cur not only due to lack of faith in posiƟ ve outcomes, but 
also due to lack of moƟ vaƟ on in regards to treatment 
procedures. In addiƟ on, physical inability is another fac-
tor that creates higher number of treatment dropouts in 
HIV-infected individuals compared to TB treatment drop-
outs. Other factors include: liƩ le or no informaƟ on on the 
part of professionals provided to people about TB treat-
ment, liƩ le organizaƟ on in the service geared toward the 
specifi c control of TB, HIV treatment is seen as a priority, 
physical structure that will not guarantee privacy, lack of 
team work, and the diﬃ  culty in accessing the service.
The lack of informaƟ on about the disease, possible 
side eﬀ ects, the importance in compleƟ ng treatment pro-
tocols even when there is an improvement in paƟ ents’ 
condiƟ on, and the severe consequences of treatment in-
terrupƟ on are infl uencing factors on treatment dropout 
rates, since they are all connected to the individuals’ feel-
ings and beliefs about tuberculosis and its aggravaƟ ons(20).
Regarding the treatment of individual carriers of TB/
HIV in the public health network, some aspects deserve 
consideraƟ on, such as the structuring and geographic lo-
caƟ on of the treatment. Since co-infected people need 
complete and resolute care, TB and HIV care in diﬀ ering 
locaƟ ons aﬀ ect and elevate costs in terms of access to 
care, contribuƟ ng to a low treatment compliance rate (7).
The co-infected individual needs mulƟ disciplinary care 
that includes medical, nursing and psychological care, so-
cial services, judicial/fi nancial assistance and referrals to 
other specialƟ es and support services which are, many 
Ɵ mes, available in the civil society organizaƟ ons. In ad-
diƟ on, these individuals need moƟ vaƟ on to comply with 
both treatments, and a structure that is capable of pre-
venƟ ng individuals from becoming dropouts and/or be-
coming non-compliant with medicaƟ on regimens.
Hence, Brazil is pracƟ cally the only country with a 
large number of co-infected individuals and a universal ac-
cess policy to anƟ -retroviral therapy; therefore, it has the 
right condiƟ ons to establish strategies that will diminish 
TB morbidity and mortality associated with HIV. The pri-
mary measures for controlling these epidemics are early 
diagnosis, appropriate treatment for carriers of TB and 
the search for exposed/infected contacts(21).
CONCLUSION
The mean scores obtained regarding access to treat-
ment demonstrate that co-infected individuals presented 
higher diﬃ  culƟ es in accessing treatment than individu-
als who are not co-infected. SituaƟ ons regarding paƟ ents’ 
transportaƟ on to health services centers (transportaƟ on 
and expenditures associated with transportaƟ on) were the 
variables that presented lower scores, therefore they de-
serve greater aƩ enƟ on from health profession managers.
Study limitaƟ ons may be related to the sample size 
of carriers undergoing treatment, poor memory and in-
formaƟ on bias. However, the data found in this study are 
capable of providing results important to the discussion of 
the profi le of individuals seeking treatment and the ser-
vice organizaƟ on of TB diagnosis, whether individuals are 
or are not co-infected with HIV.
Therefore, this present study may be used as a resource 
for municipal healthsystem planning, mainly regarding the 
integraƟ on and communicaƟ on between the Tuberculosis 
Control Program and the Sexually TransmiƩ ed Diseases Na-
Ɵ onal Program, which is seen as a facilitaƟ ng factor in the 
access to disease diagnosis and treatment.
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